NEW YORK, Jan. 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ferroglobe PLC GSM, Corbus Pharmaceuticals Holdings, Inc. CRBP, Meritage Corporation MTH, Dicerna Pharmaceuticals, Inc. DRNA, Castle Brands, Inc. ROX, and Ply Gem Holdings, Inc. PGEM, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
GSM DOWNLOAD: http://Fundamental-Markets.com/register/?so=GSM
CRBP DOWNLOAD: http://Fundamental-Markets.com/register/?so=CRBP
MTH DOWNLOAD: http://Fundamental-Markets.com/register/?so=MTH
DRNA DOWNLOAD: http://Fundamental-Markets.com/register/?so=DRNA
ROX DOWNLOAD: http://Fundamental-Markets.com/register/?so=ROX
PGEM DOWNLOAD: http://Fundamental-Markets.com/register/?so=PGEM
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Ferroglobe PLC GSM, Corbus Pharmaceuticals Holdings, Inc. CRBP, Meritage Corporation MTH, Dicerna Pharmaceuticals, Inc. DRNA, Castle Brands, Inc. ROX, and Ply Gem Holdings, Inc. PGEM on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed January 22nd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
FERROGLOBE PLC (GSM) REPORT OVERVIEW
Ferroglobe's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Ferroglobe reported revenue of $451.63MM vs $364.73MM (up 23.83%) and basic earnings per share -$0.02 vs -$0.17. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Ferroglobe reported revenue of $1,555.66MM vs $1,289.89MM (up 20.60%) and basic earnings per share -$1.97 vs -$0.43. Ferroglobe is expected to report earnings on March 15th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.09. The estimated EPS forecast for the next fiscal year is $1.40 and is expected to report on March 15th, 2018.
To read the full Ferroglobe PLC (GSM) report, download it here: http://Fundamental-Markets.com/register/?so=GSM
-----------------------------------------
CORBUS PHARMACEUTICALS HOLDINGS, INC. (CRBP) REPORT OVERVIEW
Corbus Pharmaceuticals' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Corbus Pharmaceuticals reported revenue of $0.80MM vs $0.74MM (up 7.23%) and basic earnings per share -$0.14 vs -$0.12. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Corbus Pharmaceuticals reported revenue of $1.91MM vs $0.65MM (up 194.79%) and basic earnings per share -$0.49 vs -$0.28. Corbus Pharmaceuticals is expected to report earnings on March 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.18. The estimated EPS forecast for the next fiscal year is -$0.73 and is expected to report on March 8th, 2018.
To read the full Corbus Pharmaceuticals Holdings, Inc. (CRBP) report, download it here: http://Fundamental-Markets.com/register/?so=CRBP
-----------------------------------------
MERITAGE CORPORATION (MTH) REPORT OVERVIEW
Meritage's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Meritage reported revenue of $809.15MM vs $756.00MM (up 7.03%) and basic earnings per share $1.06 vs $0.92 (up 15.22%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Meritage reported revenue of $3,041.73MM vs $2,579.46MM (up 17.92%) and basic earnings per share $3.74 vs $3.25 (up 15.08%). Meritage is expected to report earnings on February 1st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $1.22. The estimated EPS forecast for the next fiscal year is $4.61 and is expected to report on February 1st, 2018.
To read the full Meritage Corporation (MTH) report, download it here: http://Fundamental-Markets.com/register/?so=MTH
-----------------------------------------
DICERNA PHARMACEUTICALS, INC. (DRNA) REPORT OVERVIEW
Dicerna Pharmaceuticals' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Dicerna Pharmaceuticals reported revenue of $0.47MM vs $0.16MM (up 192.59%) and basic earnings per share -$0.92 vs -$0.68. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Dicerna Pharmaceuticals reported revenue of $0.30MM vs $0.18MM (up 60.33%) and basic earnings per share -$2.87 vs -$3.09. Dicerna Pharmaceuticals is expected to report earnings on March 29th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.68. The estimated EPS forecast for the next fiscal year is -$3.18 and is expected to report on March 29th, 2018.
To read the full Dicerna Pharmaceuticals, Inc. (DRNA) report, download it here: http://Fundamental-Markets.com/register/?so=DRNA
-----------------------------------------
CASTLE BRANDS, INC. (ROX) REPORT OVERVIEW
Castle Brands' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Castle Brands reported revenue of $20.89MM vs $19.63MM (up 6.45%) and basic earnings per share $0.00 vs $0.00. For the twelve months ended March 31st, 2017 vs March 31st, 2016, Castle Brands reported revenue of $77.27MM vs $72.22MM (up 6.99%) and basic earnings per share -$0.01 vs -$0.02. Castle Brands is expected to report earnings on February 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.00. The estimated EPS forecast for the next fiscal year is $0.02 and is expected to report on June 13th, 2018.
To read the full Castle Brands, Inc. (ROX) report, download it here: http://Fundamental-Markets.com/register/?so=ROX
-----------------------------------------
PLY GEM HOLDINGS, INC. (PGEM) REPORT OVERVIEW
Ply Gem's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Ply Gem reported revenue of $564.66MM vs $530.39MM (up 6.46%) and basic earnings per share $0.40 vs $0.80 (down 50.00%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Ply Gem reported revenue of $1,911.84MM vs $1,839.73MM (up 3.92%) and basic earnings per share $1.11 vs $0.47 (up 136.17%). Ply Gem is expected to report earnings on March 9th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.14. The estimated EPS forecast for the next fiscal year is $1.44 and is expected to report on March 9th, 2018.
To read the full Ply Gem Holdings, Inc. (PGEM) report, download it here: http://Fundamental-Markets.com/register/?so=PGEM
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
